Healthcare Real Estate Developer Joe Simone Says Increase in Knee Replacements Will Fuel Ambulatory Surgical Center Expansion

Joseph Simone, President of Simone Development Companies, at headquarters at Hutchinson Metro Center in the Bronx

“The construction of ambulatory centers has been strong for years, but with the pandemic and innovations in surgical procedures, the demand for these facilities is exponentially expanding,” said Joe Simone.

A projected increase in knee replacement surgeries will fuel the growth of ambulatory surgical centers, according to healthcare real estate developer Joseph Simone.

“We are experiencing a revolution in knee replacement technologies that are allowing doctors to perform minimally invasive surgeries that do not require hospital settings,” said Joe Simone, President of the Simone Development Companies, a leading developer of healthcare facilities.

“For real estate developers, that means we will see greater demand for new ambulatory surgical centers as increasing numbers of the active elderly seek solutions to joint pain.”

In June, Renub Research Analysis published a report on the global knee replacement market. Renub predicted that in the United States, the value of knee replacements will rise from $8.02 billion in 2020 to $12.87 billion by 2027, a compound annual growth rate of 6.99%.

“Knee replacements will become more common and most of them will occur in the types of ambulatory surgical centers that Simone Development Companies have built, such as the Montefiore Hutchinson Campus in the Bronx, NY,” said Joseph Simone. “By 2040, the Centers for Disease Control and Prevention estimated that 78 million adults in the U.S. will be diagnosed with arthritis.”

Patient interest in ambulatory surgical centers accelerated during the Covid-19 pandemic, when many hospitals were closed to patients who did not need life-saving interventions. Many patients who needed elective surgery like knee replacements were also reluctant to enter any facility that resembled a hospital for fear of contracting Covid-19.

“The construction of ambulatory centers has been strong for years, but with the pandemic and innovations in surgical procedures, the demand for these facilities is exponentially expanding,” said Joe Simone. “We are actively partnering with hospitals and other healthcare providers to identify locations for new construction.”

Simone Development Companies is a fully integrated private real estate investment and development company that acquires and develops healthcare, mixed-use, commercial, industrial, retail and residential properties. Headquartered at the Hutchinson Metro Center, it boasts a portfolio of over seven million square feet throughout the Bronx, Manhattan, Queens, Long Island, Westchester, Orange and Fairfield Counties and New Jersey. With services spanning acquisition, development, construction, finance, asset management, accounting, leasing and property management, Simone Development Companies is set apart by its creatively oriented management team, long-term asset ownership and its pursuit of visionary development.

Share article on social media or email:

Cirtec Medical Announces Acquisition of Cardea Catheter Innovations

News Image

This acquisition serves as another example of our commitment to building our interventional capabilities for our customers.

Cirtec Medical Corporation, a strategic outsourcing partner of complex medical devices including minimally invasive and active implantable devices, today announced that it has acquired Cardea Catheter Innovations, a vertically integrated manufacturer of minimally invasive catheter devices and complex delivery systems based in San Jose, CA.

“We are excited to add Cardea Catheter Innovations to the Cirtec team,” stated Brian Highley, Cirtec CEO. “This acquisition is a natural fit for us and serves as another example of our commitment to building our interventional capabilities for our customers following our investments into Vascotube and NovelCath.”

Cardea will integrate within the NovelCath brand, contributing to Cirtec’s Interventional segment focusing on structural heart, electrophysiology, and neurovascular applications. With experience in design, development and manufacturing, Cardea specializes in highly engineered braided and coiled reinforced catheter shafts, complex steerable and multi-directional sheath designs, medical balloons and microcatheters.

Both the current Cirtec Los Gatos design center (formerly Circle Medical) and Cardea will be relocating to a new 32,000 sq. ft. purpose-built facility in San Jose, CA. This facility will become Cirtec’s West Coast Center of Excellence for Catheters and Delivery Systems and will include catheter development, full device assembly, packaging, and volume manufacturing capabilities with a path to Cirtec Costa Rica production. The move will add a substantial expansion of manufacturing space for Cardea.

Matyou Shahbaz, Cardea CEO and founder commented, “This is an excellent opportunity for our organization, employees and most importantly our customers. We believe in Cirtec’s vision for this segment and core commitment to create value for our customers. Joining Cirtec’s Interventional segment provides tremendous career opportunities for our team and enables us to support our customers with additional capabilities and competencies with a very experienced Cirtec team.

About Cirtec Medical

Cirtec Medical is a vertically integrated, full-service outsource partner providing end-to-end product design, development, and manufacturing of Class III and II medical devices and components. We specialize in today’s most advanced product technologies including, neuromodulation, implantable drug delivery, cardiac rhythm management, ventricular assist and interventional devices and delivery systems. Cirtec has a global footprint with facilities in Brooklyn Park, MN; Chandler, AZ; El Coyol, Costa Rica; Enfield, CT; Los Gatos, CA, Lowell, MA, and Birkenfeld, Germany.

Share article on social media or email:

Avante Health Solutions Awarded Exam Room Equipment Agreement with Vizient

News Image

Avante Health Solutions is pleased to announce it has been awarded a contract with Vizient, Inc. to offer exam room equipment to its members at contracted pricing. Vizient is the largest member-driven health care performance improvement company in the nation.

Vizient’s diverse membership and customer base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and nonacute health care providers.

About Avante Health Solutions

Avante Health Solutions is pleased to announce it has been awarded a contract with Vizient, Inc. to offer exam room equipment to its members at contracted pricing. Vizient is the largest member-driven health care performance improvement company in the nation.

Share article on social media or email:

Doctors and Patients Agree That Knowledge Is The Strongest Weapon To Overcome Fibroids

Our mission is to raise awareness and empower women with all of the information to make a decision that’s best for them.

As part of its #DontLoseUrU campaign, the Free From Fibroids Foundation hosted a livestream roundtable with Act.TV to raise awareness of all available treatment options for uterine fibroids and to support H.R. 2007, the Stephanie Tubbs Jones Uterine Fibroid Research & Education Act of 2021.


The livestream event was hosted by Adrianna Hopkins of WJLA-TV in Washington, DC, and featured John C. Lipman, MD, FSIR, Founder and Chairman of FFF, as well as Paula Gwynn Grant, a board member of the foundation. In addition, three patient advocates participated by sharing their stories of living with fibroids and getting their life back after treatment.

The mission of the Free From Fibroids Foundation is to empower women with information about all of their treatment options as they battle uterine fibroids. The foundation is using the month of July, which is Fibroid Awareness month, to challenge the medical community’s outdated knee-jerk treatment of uterine fibroids with hysterectomy.

Last week, patients shared their journey battling fibroids and receiving non-surgical UFE treatment.

Dr. Lipman, the founder of the Free From Fibroids Foundation, said, “For over 25 years there has been a safe, proven method of treating fibroids that doesn’t involve surgery, and yet many women do not know this option exists. The stories I hear every day in my office just break my heart because the medical gatekeepers have promoted life-altering hysterectomies over other treatment options, like UFE, and the result is that women have lost their uterus when they didn’t need to. Our mission is to raise awareness and empower women with all of the information to make a decision that’s best for them.”

Paula Gwynn Grant, a board member of the foundation, said, “This is a topic that can be uncomfortable to discuss in public but we must have more public conversations like this because no women should have to suffer in silence with fibroids. We will continue to raise awareness and work to pass H.R. 2007 but that is just the first step. Our foundation is committed to helping women be their own health advocates and changing the landscape so hysterectomy is no longer the front-line treatment for fibroids.”

For more information on Free From Fibroids, The Fibroid Coalition, or to support H.R. 2007, please visit our website at

Share article on social media or email:

Lateral Patient Transfer Technology Available on the Ocean Tomo Bid-Ask™ Market Addresses Growing State Requirements for Safe Patient Handling

Safe patient handling legislation has been passed in eleven states, including California, Illinois, New York, New Jersey, and Texas. The technology in Ocean Tomo Bid-Ask lot 140 benefits healthcare workers and the companies that employ them.

The Centers for Disease Control and Prevention (CDC), reports on patient handling hazard statistics outlined by the National Institute for Occupational Safety and Health (NIOSH) based on data compiled by the Bureau of Labor Statistics (BLS). BLS data from 2014 indicates the rate of injuries caused by overexertion across all industries was 33 per 10,000 full-time workers. The rate for nursing home workers is three times the national average and the rate for hospital workers two times the national average. NIOSH indicates the greatest risk factor for overexertion among healthcare workers is manual patient lifting, moving, and repositioning. Ocean Tomo Transactions, LLC will auction a portfolio of four U.S. patents and three U.S. trademarks for safe patient handling, a no-lift-required lateral patient transfer system. The portfolio covers a motorized lateral transfer device (Magic Mover™) and a transfer/repositioning sheet (Magic Sheet™). The entire portfolio is available through the Ocean Tomo Bid-Ask™ Market, auction lot 140. This innovative technology enables efficient patient transfer while helping to avoid injury and discomfort to caregivers and patients.

Safe patient handling legislation has been passed in eleven states, including California, Illinois, New York, New Jersey, and Texas. This invention benefits healthcare workers and the companies that employ them. The Innovation Group Board of Managers reinforces this technology’s importance and economic value, sharing “caregiver injuries due to lifting patients is rampant. We want to help caregivers and institutions transfer patients without lifting, helping mitigate Worker’s Compensation claims.”

View a video demonstration of the technology on the Ocean Tomo Bid-Ask market. To request bidder credentials or further information on this auction or other portfolios on the Ocean Tomo Bid-Ask™ Market, contact Olivia Becker at or +1 747 277 9337.

About Ocean Tomo Bid-Ask™ Market

The Ocean Tomo Bid-Ask Market is an open online platform to buy and sell patents. This market is an important step forward, both as a simplified solution for patent transactions as well as a source of information on patent pricing. The Ocean Tomo Bid-Ask Market uniquely combines the efficiency of an online platform with an experienced team of brokers fluent in both English and Mandarin. The market uses standard transaction documents and is open, transparent, and free to view.

Share article on social media or email:

Catalent Launches New OptiDose® Design Solution to Help Create Differentiated Treatments that are Successful for Innovators, Patients and Health Care Professionals

The OptiDose Design platform looks to evaluate all these considerations and provide options for final dose form decisions with an optimal combination of patient acceptance and adherence, differentiation versus any standard of care, manufacturability and cost

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the launch of its new OptiDose® Design Solution, at the Controlled Release Society (CRS) annual meeting, which is taking place virtually from July 25 – 29, 2021.

Catalent’s OptiDose Design Solution, led by Catalent’s scientific advisors, uses a design approach that combines data-driven scientific tools with Catalent’s extensive development expertise. Integrating pharmaceutics, and dose form design target patient characteristics, OptiDose Design Solution will help craft the ideal dose form for all stakeholders and optimize the potential of a molecule.

“Taking patient needs and market realities into consideration earlier in the drug development process, along with critical CMC and DMPK parameters, is vital for creating a successful treatment for patients, innovators and health care professionals alike,” commented Julien Meissonnier, Chief Scientific Officer at Catalent. He continued, “The OptiDose Design platform looks to evaluate all these considerations and provide options for final dose form decisions with an optimal combination of patient acceptance and adherence, differentiation versus any standard of care, manufacturability and cost.”

At the CRS meeting, Lisa Caralli, Director of Science and Technology at Catalent, will discuss the methodology of the OptiDose Design Solution, including how key product and patient factors are evaluated. Ms. Caralli’s presentation, titled “Strategies to Optimize the Dose Design Process to Create Better Treatments”, will use case studies to demonstrate how the correct guidance, at the optimum time, can help drug developers create better treatments.

Ms. Caralli has over 27 years of industry experience, and in her role at Catalent, works with pharmaceutical companies to identify appropriate development pathways for early development drug candidates. She has previously held roles at Ionis Pharmaceuticals and Amylin Pharmaceuticals and began her career at the Immune Response Corporation. Ms. Caralli holds a bachelor’s degree in biochemistry from the University of California at Davis, California.

OptiDose Design Solution is available throughout Catalent’s global oral dose network. For more information, please visit

About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs approximately 15,000 people, including around 2,400 scientists and technicians, at more than 45 facilities, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

Summit BHC Expands Presence in Colorado With the Opening of Johnstown Heights Behavioral Health

Summit BHC (“Summit”), a leading national provider of behavioral health and addiction treatment services, has opened Johnstown Heights Behavioral Health in Johnstown, CO.

Johnstown Heights Behavioral Health provides a full range of treatment services, including mental health crisis intervention, inpatient treatment, medication management, and intensive therapy for mental health issues. Johnstown Heights will also treat substance use disorder through a full continuum of care, including medically managed detox and intensive inpatient services. The facility has 92 beds that will serve adults, children and adolescents.

“The addition of Johnstown Heights Behavioral Health allows Summit to continue providing quality, affordable mental health and substance use disorder treatment to the residents of Colorado,” says Brent Turner, CEO of Summit. “This is an exciting expansion for us as we grow our services and reach more people in need of quality behavioral health services.”

Summit has 24 inpatient facilities nationally. This is its second in Colorado, in addition to Peak View Behavioral Health in Colorado Springs.

About Summit

Headquartered in Franklin, Tennessee and founded in 2013, Summit was established to develop and operate a leading network of behavioral health hospitals and addiction treatment centers throughout the country. The company’s primary focus is on psychiatric services and substance use disorder treatment within a flexible and dynamic continuum of care. The leadership team at Summit is composed of senior executives with decades of combined experience in the behavioral healthcare industry at the national level. The company currently owns and operates 24 freestanding facilities nationwide.

Share article on social media or email:

DayBreak’s Innovation to Reduce Emergency Services Usage is Honored with John A. Hartford Foundation Award from n4a

The Rapid Response Case Management (Rapid Response) program of DayBreak Adult Care Centers (DayBreak) received honorable mention for a Business Innovation Award for helping to create an age-friendly community in Alameda County.

In the first year of the program, Rapid Response improved healthcare and social support services for 70 clients, which reduced their frequent use of 911, EMS and emergency rooms, resulting in an estimated $2 million savings in hospital costs.

The innovative model demonstrates the catalyzing role that community-based organizations like DayBreak can take to drive meaningful change.

Business Innovation Award, Honorable Mention:

The National Association of Area Agencies on Aging’s (n4a) Aging and Disability Business Institute presented DayBreak with The John A. Hartford Foundation 2021 Business Innovation Award Honorable Mention for its Rapid Response Case Management program. The award was presented at n4a’s 46th Annual Conference and Tradeshow on July 21, 2021.

“Rapid Response is a model for how local agencies, community organizations and nonprofits can work together to improve lives,” said Ofra Paz, Executive Director of DayBreak. “We are honored to be recognized by n4a’s Aging and Disability Business Institute and The John A. Hartford Foundation. They share our commitment to better care for older adults that lowers overall costs.”

“We applaud the nominee organizations, all of whom are indispensable to their communities and have shown great ingenuity resilience and resourcefulness,” said Terry Fulmer, PhD, RN, FAAN, President of The John A. Hartford Foundation. “This award hopes to inspire all community-based organizations to create age-friendly partnerships with hospitals, health plans and with one another through regional networks.”

Rapid Response Improves Lives and Communities:

In many communities, there are people who call 911 frequently because they lack access to health care and social services. Instead, they use emergency medical services weekly or more frequently. Frequently, these are vulnerable, older adults with complex health and social needs, who are also low-income.

Rapid Response addresses the needs of these high-utilization people. Rapid Response connects clients with much-needed health and social supports and provides ongoing case management, reducing the use of 911 and hospital emergency rooms for these needs.

In Alameda County, California, the Rapid Response partnership includes Alameda County Emergency Medical Services (EMS), area hospitals, fire departments, Adult Protective Services, community-based organizations, and DayBreak. This strategic partnership of 20 organizations launched in 2018, with the goal of reducing the high utilization of EMS by older adults for non-emergency issues.

DayBreak facilitated the design process for Rapid Response. DayBreak invited local partners to an ongoing series of workshops to design the solution together.

Key to the program’s success in Alameda County is fast referrals. DayBreak professionals meet clients at the hospital shortly after the client calls 911 and EMS is contacted.

At the hospital, DayBreak assesses the person’s unmet needs. DayBreak then draws on the local network to bring in the needed services and supports. This allows the client to leave the hospital and safely go home, where they can live independently and healthier – with the right supports in place. DayBreak continues to follow-up with each client to ensure their wellbeing.

Replicating Rapid Response:

“Our goals are to help more elders in the East Bay, and to support other communities in designing Rapid Response for their specific needs. We view our role as that of facilitator, not program owner. We guide disparate teams to find common ground and co-create solutions. These solutions improve health, energize teams and lift-up communities,” said Ofra Paz.

Beginning with only a small amount of seed money in 2018, DayBreak secured additional grant funding and hired a team of full-time staff to support the program.

About DayBreak

DayBreak Adult Care Centers (“DayBreak”) improves the lives of vulnerable older adults and their family caregivers. In addition to the Rapid Response Case Management program, key programs include:

  • Co-op adult day community pilot program, where caregivers can donate volunteer hours in exchange for respite care;
  • Caring-for-the-Caregiver education series;
  • Senior injury- and fall-prevention programs;
  • Phone counseling and assistance for seniors and caregivers.

Learn more at

About The John A. Hartford Foundation

The John A. Hartford Foundation, based in New York City, is a private, nonpartisan, national philanthropy dedicated to improving the care of older adults. The leader in the field of aging and health, the Foundation has three priority areas: creating age-friendly health systems, supporting family caregivers and improving serious illness and end-of-life care. For more information, visit and follow @johnahartford.

About n4a

The National Association of Area Agencies on Aging (n4a) is a 501(c)(3) membership association representing America’s national network of 622 Area Agencies on Aging (AAAs) and providing a voice in the nation’s capital for the more than 260 Title VI Native American aging programs. n4a’s primary mission is to build the capacity of our members so they can help older adults and people with disabilities live with dignity and choices in their homes and communities for as long as possible. For more information, visit and follow @n4aACTION.

About the Aging and Disability Business Institute

The mission of n4a’s Aging and Disability Business Institute is to build and strengthen partnerships between aging and disability community-based organizations and the health care system. The Business Institute receives funding from The John A. Hartford Foundation, The SCAN Foundation and the Administration for Community Living and is led by n4a.

Abridge and Mila partner to apply advances in AI to medical conversations

News Image

The healthcare AI startup that helps patients better stay on top of their health, Abridge, announced a partnership with the University of Montreal AI research institute Mila. The collaboration will deepen research contributions to the rapidly evolving field of medical conversation understanding and expand Abridge’s machine learning capabilities.

“Our mission at Abridge is to help people understand and follow-through on their health — much of which is powered by machine learning,” said Sandeep Konam, CTO and co-founder of Abridge. “From our earliest days, our goal has been to advance medical conversation AI and improve healthcare delivery experiences for people and their doctors. Our partnership with Mila gives us the opportunity to expand our research and continue to engage with leading innovators. The progress we make together will benefit many more people than either of us might reach on our own.”

Abridge highlights the key details of medical conversations, including instructions, medications, and follow-ups, making it easier to revisit important details and share the conversation with family. Abridge also shares clinically structured summaries with health professionals to help them save time and focus on patient experiences and outcomes. To solve complex challenges in understanding and summarizing medical conversations, the company invested upfront in annotating a one-of-a-kind, de-identified dataset containing over 10,000 hours of transcribed conversations from fully informed and consenting patients. Using this rich dataset, they built domain adaptation modules that can correct transcription errors, classifiers that can flag key takeaways, and language generation models that can create actionable summaries. Abridge contributes regularly to premier machine learning conferences and workshops, in the spirit of promoting open research and collaborating closely with academic communities.

Mila’s dedication to the socially responsible and beneficial development of AI closely aligns with Abridge’s commitment to ensuring that their technology is distributed fairly to all groups and will lead to more medical comprehension for everyone. “Since our founding, we’ve been committed to solving problems according to people’s real needs and pursuing the development of AI for social good,” said Yoshua Bengio of Mila. “That’s why we’re looking forward to partnering with Abridge — not only for our shared focus on machine learning, but also because we are both dedicated to developing technology responsibly and in service of others.”


Abridge helps people stay on top of their health. Whether an appointment takes place in-person or at home via telemedicine, Abridge records the conversation and creates an interactive transcript highlighting the key medical points. By keeping patients, their families, and clinicians on the same page, Abridge brings more understanding and follow-through to every conversation. Visit and @AbridgeHQ to get the latest information.


Founded by Professor Yoshua Bengio of the Université de Montréal, Mila is a research institute in artificial intelligence which rallies about 700 researchers specializing in the field of deep learning. Based in Montreal, Mila’s mission is to be a global pole for scientific advances that inspires innovation and the development of AI for the benefit of all. Mila is a non-profit organization recognized globally for its significant contributions to the field of deep learning, particularly in the areas of language modelling, machine translation, object recognition and generative models.

Share article on social media or email:

Boston IVF and Reproductive Care Center Announce New Partnership

Reproductive Care Center

Both Boston IVF and Reproductive Care Center have a shared vision to deliver the highest quality of integrated, holistic care and help our patients become parents in the shortest time possible.

Boston IVF, a pioneer in reproductive healthcare and innovative research, announced it has entered into a partnership with Reproductive Care Center, a leading provider of fertility and family-building services in Utah and Idaho.

As individuals and couples continue to seek reproductive care across the country at historically high levels during the COVID-19 pandemic, the new partnership enables Reproductive Care Center (RCC) to further enhance its standing as a clinical leader in the region. Boston IVF’s vast library of data analysis and clinical protocols lead to less time in treatment, less total cost, and an improved chance for success. Additionally, RCC and future patients will benefit from Boston IVF’s robust scientific team and international research program, which regularly conducts pioneering clinical trials that contribute to industry-wide improvements in all aspects of care – including egg and embryo development.

With the acquisition of RCC, Boston IVF continues to expand its national fertility network, which now includes over 30 reproductive endocrinologists across 30 centers nationwide. In March, Boston IVF acquired Ohio Reproductive Medicine, Central Ohio’s largest IVF program.

“We are pleased to welcome such a respected leader in reproductive medicine to the Boston IVF fertility network,” said David Stern, MBA – Chief Executive Officer of Boston IVF. “Both Reproductive Care Center and Boston IVF have a shared vision to deliver the highest quality of integrated, holistic care and help our patients become parents in the shortest time possible. RCC’s long history of scientific innovation and clinical success aligns perfectly with our business model, philosophy, and mission.”

As part of the new partnership, Reproductive Care Center – which operates four centers across Utah and Idaho – also welcomes incoming reproductive endocrinologist Kristi Maas, MD to its Salt Lake City-based team. Dr. Maas joins RCC from a leading Southern California fertility practice, where she played a significant role in assisting individuals and couples with their family-building needs. Additionally, her arrival at RCC/Boston IVF serves as a long-awaited reunion; Dr. Maas is a graduate of the prestigious Beth Israel Deaconess Medical Center/Harvard Medical School/Boston IVF Reproductive Endocrinology and Infertility (REI) Fellowship program, which trains the country’s top-tier fertility specialists.    

“It is very important for us to join forces with a leader that shares our vision of the future,” said James Heiner, MD – Reproductive Care Center founder and chief reproductive endocrinologist. “The RCC/Boston IVF partnership offers us the unique opportunity to implement substantial clinical, scientific, and operational enhancements that differentiate us from other centers and positively impact the lives of our patients. To add Boston IVF’s resources, experience, and reproductive lab science – which directly influences success rates – to an already highly-effective model of care is a significant and compelling opportunity for those in our local community who wish to build a family.”

“Boston IVF admires Reproductive Care Center’s desire to expand,” said Haryanto Hokianto, Vice President of Business Development at Boston IVF. “We applaud Dr. Keith Blauer and fellow RCC team members for their progressive vision of reproductive care and dedication to creating unique financing programs that help to make treatment affordable. As a strategic partner, it is important for our local physicians to operate autonomously and work collaboratively to grow the practice and enhance an already-superior level of RCC patient care in Utah and Idaho.”


Boston IVF is one of the largest and most experienced fertility networks in the United States, with more than 100,000 babies born since 1986. Founded as one of the nation’s first private practice IVF centers, the Boston IVF network has grown to include over 30 reproductive endocrinologists across 30 centers throughout Massachusetts, Maine, New Hampshire, New York, Idaho, Indiana, Ohio, Rhode Island, and Utah. A renowned innovator of reproductive technologies, advanced protocols, and cutting-edge research, Boston IVF has achieved numerous “firsts” in the field of reproductive care. Its scientific and research arm continues to pave the way for breakthroughs in fertility care and its accredited REI Fellowship Program has graduated numerous reproductive endocrinologists as part of its mission to train the next generation of fertility experts. In 2019, this leading provider of fertility services in the United States was acquired by Eugin, one of the largest IVF networks in the world, with centers throughout Europe and South America. For more information, please visit


Reproductive Care Center, the first private practice fertility clinic in Utah, has helped individuals and couples to build their families for over 25 years. Utilizing the most innovative and medical protocols, RCC offers a full array of services including IUI, IVF, egg freezing, donor egg IVF, genetic testing, male infertility, LGBTQIA+ family-building and more. Utilizing a myriad of proven reproductive technologies, RCC is able to identify unique trends that often lead to a swifter, more accurate diagnosis for the rarest of infertility cases. For more information, please visit

Share article on social media or email:

Press Release News Wire Service